WHO panel says no evidence yet that new omicron subvariants are more dangerous than others that are circulating

日本 ニュース ニュース

WHO panel says no evidence yet that new omicron subvariants are more dangerous than others that are circulating
日本 最新ニュース,日本 見出し
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 47 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 97%

The omicron sublineages named BQ.1 and XBB do not appear to have immune escape mutations that warrant being designated as variants of concern, said a WHO advisory panel. As of Oct. 25, the XBB and XBB.1 lineages had been detected in 35 countries.

The omicron sublineages named BQ.1 and XBB do not appear to have immune escape mutations that warrant being designated as variants of concern, a World Health Organization advisory panel said Friday.

As of Oct. 25, the XBB and XBB.1 lineages had been detected in 35 countries, according to a WHO weekly update from Thursday. The two are BA.2.10.1 and BA.2.75 recombinants, which were found in 26 countries in the previous week. “While there are no data on severity or immune escape from studies in humans, BQ.1* is showing a significant growth advantage over other circulating Omicron sublineages in many settings, including Europe and the US, and therefore warrants close monitoring,” said the panel.

Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began• Gilead Sciences Inc. GILD, +12.92% said sales of its COVID treatment Veklury, formerly known as remdesivir, fell 52% to $925 million in the third quarter, driven by lower rates of COVID-19-related hospitalizations compared to the third quarter of 2021.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

MarketWatch /  🏆 3. in US

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Omicron subvariants resistant to key antibody treatments are increasing every week in the U.S.Omicron subvariants resistant to key antibody treatments are increasing every week in the U.S.The subvariants BQ.1 and BQ.1.1 now represent 27% of infections in the U.S., a significant jump from the week prior when they made up about 16% of new cases.
続きを読む »

COVID ‘variant soup’ is making winter surges hard to predictCOVID ‘variant soup’ is making winter surges hard to predictDescendants of Omicron are proliferating worldwide — and the same mutations are coming up again and again.
続きを読む »

New Covid Boosters Aren't Better Than Old Shots at Neutralizing Omicron BA.5, Early Studies FindNew Covid Boosters Aren't Better Than Old Shots at Neutralizing Omicron BA.5, Early Studies FindTwo independent studies suggest the new Covid booster shots don’t protect better against omicron BA.5 than the original vaccines.
続きを読む »

Obama comments on Pelosi attack, says 'dangerous climate' is created when people begin 'demonizing' othersObama comments on Pelosi attack, says 'dangerous climate' is created when people begin 'demonizing' othersFormer President Barack Obama said 'more people can get hurt' if elected officials don't do more to reject dangerous rhetoric in America.
続きを読む »



Render Time: 2025-03-06 17:49:45